FDA approves CAR T-cell therapy for lymphomaMay 2, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Predicting response to CAR T-cell therapy in CLLMay 1, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Team identifies 5 subtypes of DLBCLMay 1, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
CHMP recommends approval for generic carmustineApril 28, 2018Lymphoma & Plasma Cell DisordersPharmacyHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Radioimmunoconjugate shows activity in NHLApril 27, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
CDK inhibitor synergizes with venetoclax in CLLApril 26, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
FDA places tazemetostat trials on partial holdApril 25, 2018Lymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Art education benefits blood cancer patientsApril 23, 2018AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaHematology NursingTransplantationAML
Inhibitor outperforms rivals in leukemia, lymphomaApril 20, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLNon-Hodgkin LymphomaAggressive Lymphomas
Team uses iPSCs to create ‘universal’ CAR T cellsApril 20, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersALLNon-Hodgkin LymphomaAggressive Lymphomas
Research reveals new subtypes of DLBCLApril 12, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Tazemetostat exhibits antitumor activity in phase 1 trialApril 11, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Combo improves outcomes in MCLApril 10, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Duvelisib NDA granted priority reviewApril 10, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Project provides ‘unprecedented understanding’ of cancersApril 6, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersRelated IssuesAMLNon-Hodgkin LymphomaAggressive Lymphomas
